novartis glp-1 receptor agonist Agonists: The New Wave in Diabetes Management GLP-1 Receptor Agonist Market Size,

Description

Poor nutrition and obesity disproportionately affect individuals with lower socioeconomic status in rural communities and in racial and ethnic minoritized populations [226], and disparities in poor nutrition and obesity prevalence are mirrored in disparities in access to quality health care [227]

Healthcare professionals should provide comprehensive counselling about realistic expectations, potential side effects, and the importance of lifestyle modifications alongside pharmacotherapy for optimal outcomes in cardiometabolic health

Published in Nature Communications, the study suggests that GLP-1based weight-loss medications could represent a promising new therapeutic strategy for improving recovery after a heart attack